Nareg Sagherian

Vice President, Global Head of Investor Relations and Corporate Communications (Nasdaq Eols) @Evolus

Newport Beach, CA, US
EMAILS
n••••••••@evolus.com
MOBILE NUMBERS
+18•••••••14

Signup · Get unlimited contacts

WORK HISTORY

Dec 2023 — Present

Vice President, Global Head of Investor Relations and Corporate Communications (Nasdaq Eols) @Evolus

View department →

Newport Beach, CA, US

Strategic Investor Relations Counseling: Assure adherence to SEC regulations and maintain compliance with NASDAQ surveillance on financial reporting issues, while remaining current on trends in the market/market opinions, attitudes, reactions to company issues, and provide strategic recommendations to investment, operating and financial decisions to executive management• Strategic Communications Planning: Direct, develop, and execute a proactive external communications plan that reinforces overall business objectives and ensures consistency in messaging and strategy that will support the corporate brand and business initiatives• Corporate Public Relations: Establish and cultivate relationships with all media, consumer and trade related publications that allows for global, national, and local press, further strengthening the Company\'s image, and supporting specific messages designed to reinforce the Company as a leader in its sector

EDUCATION

2000 — 2005

University of Michigan College of Literature, Science, and the Arts

Bachelor of Science (B.S.), Biology/Biological Sciences

2006 — 2009

Wayne State University School of Medicine

Master of Science (M.S.), Medical Clinical Sciences/Biomedical Sciences

2011 — 2013

The Johns Hopkins University - Carey Business School

Master of Science (M.S.), Banking and Finance

2000 — 2005

University of Michigan College of Literature, Science, and the Arts

Bachelor of Science (B.S.), Neuroscience

2000 — 2005

University of Michigan College of Literature, Science, and the Arts

Bachelor of Arts (B.A.), Near and Middle Eastern Studies

2011 — 2013

The Johns Hopkins University - Carey Business School

Graduate Diploma, Investments and Securities

2014 — 2015

Georgetown University

Graduate Diploma, Legislative Affairs - Congress, Intelligence, and National Security Policy

2019 — 2021

University of Virginia Darden School of Business

Master of Business Administration - MBA, Faculty Award for Academic Excellence (Top 10%)

SKILLS

Financial AnalysisInternational RelationsInternational DevelopmentProject FinanceEnergy PolicyCorporate FinanceSocial MediaFinancial ReportingFinancial ModelingFinancial AccountingRenewable EnergyInternational TradeInternational FinanceHealthcareDigital MediaInternational BusinessMobile TechnologyBiotechnologyMedical ResearchMedia RelationsSocial Media MarketingOperations ResearchSecurity ClearanceInternet SecurityStructured FinanceOperations ManagementTradingFinancial ManagementFinancial MarketsLeveraged FinanceQuantitative FinanceHealthcare ManagementHealth EconomicsHealthcare ConsultingHealthcare TechnologyEnergy TradingAlternative EnergyEnergy ManagementTechnology DevelopmentTechnology Planning

ABOUT NAREG SAGHERIAN

A highly accomplished and seasoned senior-level finance professional with over 20 years of experience focusing on international capital markets, strategy consulting, corporate affairs, and short/long-term portfolio investments. Currently, I am Vice President, Global Head of Investor Relations and Corporate Communications at Evolus, Inc.(NASDAQ: EOLS), a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform.I recently served as Executive Director, Head of Global Investor Relations, Corporate Affairs for Intercept Pharmaceuticals, Inc.(NASDAQ: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases. Intercept Pharmaceuticals was recently acquired by AlfaSigma S.p.A. for ~$800M (Ex-U.S. Ocaliva in PBC previously acquired by Advanz Pharma for up to ~$450M).Prior to, I was Managing Director, Capital Markets & Public Affairs within the Healthcare & Life Sciences practice at FTI Consulting (NYSE: FCN), a global management consulting firm, where I developed and executed client engagements related to Mergers & Acquisitions, IPOs, shareholder activism, among other issue and event-based work. Previously, I was Managing Director of Investor Relations and Programming at the Biotechnology Innovation Organization (BIO), a global trade association representing the biotechnology and pharmaceutical industries. In this capacity, I was the primary liaison between BIO, its member companies, and third party stakeholders, such as investors (over $500 billion in capital represented), academic institutions, and government organizations.A passionate academic, I most recently completed my MBA at the University of Virginia Darden School of Business, receiving the Faculty Award for Academic Excellence and graduating in the top 10% of the 2021 cohort. I recently completed a Graduate Diploma in National Security Policy at Georgetown University’s Government Affairs Institute. I have a Master of Science in Corporate Finance and a Graduate Diploma in Investments from the Johns Hopkins University Carey Business School, a Master of Science in Biomedical Sciences from the Wayne State University School of Medicine, as well as a Bachelor of Science in Biology, Bachelor of Science in Neuroscience, and a Bachelor of Arts in Near Eastern Studies from the University of Michigan-Ann Arbor.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.